Treffer: A novel 2-metagene signature to identify high-risk HNSCC patients amongst those who are clinically at intermediate risk and are treated with PORT

Veröffent­licht:
Freiburg : Universität, 2022
Umfang:
1 Online-Ressource
Format:
E-Book
Sprache:
Englisch
Anmerkungen:
Cancers. - 14, 12 (2022) , 3031, ISSN: 2072-6694
DOI:
10.3390/cancers14123031